RPG Life Sciences scouts for larger API assets after ₹215 cr acquisitions
The drugmaker has more than ₹500 crore of capital available and is evaluating businesses that can add differentiated chemistry, regulatory access and export capabilities
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- FSSAI takes action against British Life Sciences over expired infant food business-standard.com
- Nepal billionaire’s Wai Wai maker faces FSSAI action economictimes.indiatimes.com